reports
Soleno Therapeutics Announces Pricing of $200 Million Public Offering ...
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it has priced its previously announced underwritten public offering of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. All of the shares are being sold by Soleno. In addition, Soleno has granted the underwriters a 30-day option to purchase up to an ad...
Soleno Therapeutics Announces Proposed $200 Million Public Offering of...
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell $200 million of shares of its common stock in an underwritten public offering. In addition, Soleno intends to grant the underwriters a 30-day option to purchase up to an additional $30 million of shares of common stock. The proposed public offering is subject ...
Soleno Therapeutics Announces Preliminary Financial and Operational Re...
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025 REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today certain preliminary unaudited financial and operational results for the three months ended June 30, 2025: Soleno expects its net revenue from the sales of VYKATTM XR, for the three months ended June 30, 2025 to be between $31.0 million and $33.0 million....
Soleno Therapeutics Inc: 1 director
A director at Soleno Therapeutics Inc sold 3,830 shares at 82.760USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Soleno Therapeutics Announces Two Presentations Featuring VYKAT(TM) XR...
Soleno Therapeutics Announces Two Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ENDO 2025 REDWOOD CITY, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that two abstracts featuring data on VYKAT™ XR (diazoxide choline) extended-release tablets, previously known as DCCR, have been selected for presentation at the Annual Meeting of the Endocrine Society (ENDO 2025), which is being held July 12-15, 2025, in San Francisco...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
AVAV AEROVIRONMENT INC.
KFS KINGSWAY FINANCIAL SERVICES
PAYS PAYSIGN INC
PRCH PORCH GROUP INC (A)
SPNT SIRIUSPOINT LTD
MSGE MADISON SQUARE GARDEN ENTERTAINMENT
OSCR OSCAR HEALTH
JOBY JOBY AVIATION INC
COIN COINBASE GLOBAL INC
EVEX EVE HOLDING INC
GCT GIGACLOUD TECHNOLOGY INC
CRBG COREBRIDGE FINANCIAL INC.
SGHC SUPER GROUP (SGHC) LIMITED
RDW REDWIRE CORP
DAVE DAVE INC
GRALV GRAIL INC.
SMCI SUPER MICRO COMPUTER INC.
EVTL VERTICAL AEROSPACE LTD.
ANET ARISTA NETWORKS INC
OWLT OWLET INC
ESP BROMPTON ENERGY SPLIT CORP
Oxbridge / SurancePlus CEO Jay Madhu to Speak during Ethereum Communit...
Oxbridge / SurancePlus CEO Jay Madhu to Speak during Ethereum Community Conference (EthCC) – Cannes, at the Gamma Prime Investor Forum GRAND CAYMAN, Cayman Islands, June 26, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“Oxbridge Re”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary , today announced its participation during the , to be held in Cannes, France, June 30–July 3, 2025. The event brings together blockchain builders, institutional investors, and capital allocators from around the world to explore the next wave of decentr...
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 Un...
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference REDWOOD CITY, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today highlighted new data on VYKATTM XR (diazoxide choline) extended-release tablets, previously known as DCCR, at the 2025 United in Hope: International Prader-Willi Syndrome Conference. “We believe that these data reveal critical insights on the potential...
Oxbridge / SurancePlus Commences Strategic Review of Potential Digital...
Oxbridge / SurancePlus Commences Strategic Review of Potential Digital Asset Treasury and SurancePlus Carve Out GRAND CAYMAN, Cayman Islands, June 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“Oxbridge Re”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary , today announced an update to its previously announced strategic business review to maximize shareholder value. The Company is actively reviewing a range of strategic initiatives for the company or its Web3 subsidiary, —including a potential carve-out and Nasdaq listing of ...
Soleno Therapeutics Announces Multiple Presentations at the 2025 Unite...
Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the Foundation for Prader-Willi Research, and the International Prader-Willi Syndrome Organisation REDWOOD CITY, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced one oral and six poster presentatio...
Oxbridge / SurancePlus to Speak at Yield Day NYC and Attend Permission...
Oxbridge / SurancePlus to Speak at Yield Day NYC and Attend Permissionless IV GRAND CAYMAN, Cayman Islands, June 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“Oxbridge Re”), together with its subsidiary , is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized reinsurance securities and in providing reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States. Today, the company is pleased to announce its upcoming participation in and , two leading events advancing real-world asset (RWA) innovation and institutional ad...
Oxbridge / SurancePlus Announces Partnership with Midnight Foundation ...
Oxbridge / SurancePlus Announces Partnership with Midnight Foundation to Launch Privacy-Enabled Tokenized Reinsurance Offering on the Midnight Network GRAND CAYMAN, Cayman Islands, June 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“Oxbridge Re”), together with its subsidiary , is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized reinsurance securities and in providing reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States. Today, the company has announced a strategic partnership with the , the organization supp...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
PEB PEBBLEBROOK HOTEL TRUST
MG MISTRAS GROUP
ELY CALLAWAY GOLF COMPANY
NHF NEXPOINT CREDIT STRATEGIES FUN
IOVA IOVANCE BIOTHERAPEUTICS INC
MPB MID PENN BANCORP INC.
RSSS RESEARCH SOLUTIONS
BBDC BARINGS BDC INC.
AMPY AMPLIFY ENERGY
COOK TRAEGER
STGW INC.
TYRA STAGWELL INC
NCDL TYRA BIOSCIENCES INC
ABL NUVEEN CHURCHILL DIRECT LENDING CORP
ABACUS GLOBAL MANAGEMENT INC.
Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosin...
Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2 Initial Data from the Ongoing, Blinded Phase 1 Single-Ascending Dose Trial Has Demonstrated Favorable Safety and Pharmacokinetics IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; Notice Received from FDA Placing Clinical Hold on IND Application to Open U.S. Sites CARLSBAD, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for s...
Oxbridge / SurancePlus to Attend Money20/20 Europe in Amsterdam
Oxbridge / SurancePlus to Attend Money20/20 Europe in Amsterdam GRAND CAYMAN, Cayman Islands, June 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ) (“Oxbridge Re”), together with its subsidiary , is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized reinsurance securities and in providing reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States. The company today announced its participation in Money20/20 Europe 2025, taking place June 3–5, 2025, in Amsterdam, Netherlands. Money20/20 Europe 2025 Recognized as one of th...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TRS TRIMAS CORPORATION
TLYS TILLYS
PENN PENN NATIONAL GAMING INC.
PEB PEBBLEBROOK HOTEL TRUST
MCY MERCURY GENERAL CORPORATION
LTRX LANTRONIX INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
FLO FLOWERS FOODS INC.
BUSE FIRST BUSEY CORPORATION
VFF VILLAGE FARMS INTERNATIONAL IN
EXP EAGLE MATERIALS INC.
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BDL FLANIGAN'S ENTERPRISES INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
BXC BLUELINX HOLDINGS
HAIN THE HAIN CELESTIAL GROUP
GPMT INC.
NHF GRANITE POINT MORTGAGE TRUST INC.
BCBP NEXPOINT CREDIT STRATEGIES FUN
BRT BCB BANCORP INC.
PMTS BRT APARTMENTS
MPB CPI CARD GROUP
NWPP MID PENN BANCORP INC.
RFL NEW PEOPLES BANKSHARES INC.
KKR RAFAEL HOLDINGS CL B
REZI KKR & CO. INC.
LBSRD RESIDEO TECHNOLOGIES
XRX INC.
VLA LIBERTY STAR URANIUM & METALS
INNV XEROX HOLDINGS CORPORATION
ALIT ARBOR METALS
TCRX INNOVAGE HOLDING
UDMY ALIGHT
BHRB INC. / DELAWARE
OPAL FIRST EAGLE ALTERNATIVE CAPITAL BDC INC
PRME UDEMY INC
VFC BURKE & HERBERT BANK & TR/VA
UHG OPAL FUELS INC
HYLN PRIME MEDICINE INC
NCDL VF CORPORATION
PROP UNITED HOMES GROUP INC
FIP HYLIION HOLDINGS CORP.
TXO NUVEEN CHURCHILL DIRECT LENDING CORP
NEO PRAIRIE OPERATING CO.
JEQ FTAI INFRASTRUCTURE INC
MORNINGSTAR PARTNERS
L.P.
NEO CORPORATE PUBLIC COMPANY LIMITED
THE JAPAN EQUITY FUND
INC.
- Dave Nicoski
- Ross LaDuke
RCKY ROCKY BRANDS
PZZA PAPA JOHN'S INTERNATIONAL INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
MU MICRON TECHNOLOGY INC.
MSA MSA SAFETY INC.
MPC MARATHON PETROLEUM CORPORATION
MCHP MICROCHIP TECHNOLOGY INCORPORATED
KOP KOPPERS HOLDINGS INC.
GPC GENUINE PARTS COMPANY
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CVGW CALAVO GROWERS INC.
BEN FRANKLIN RESOURCES INC.
AAP ADVANCE AUTO PARTS INC.
MEG. MEG ENERGY CORP.
FSLR FIRST SOLAR INC.
KALU KAISER ALUMINUM CORPORATION
PVH PVH CORP.
NHC NATIONAL HEALTHCARE CORP.
ELF E.L.F. BEAUTY INC.
DK DELEK US HOLDINGS INC
SCPH SCPHARMACEUTICALS INC
MTW MANITOWOC COMPANY INC.
TTEC TTEC HOLDINGS INC.
ADNT ADIENT PLC
ULBI ULTRALIFE
ELAN ELANCO ANIMAL HEALTH INC.
OCGN OCUGEN INC
ITOS ITEOS THERAPEUTICS
ETWO E2OPEN PARENT HOLDINGS INC (A)
PAX PATRIA INVESTMENTS
VAL VALARIS LTD
DINO HOLLYFRONTIER CORP
NE NOBLE CORP (NEW)
ADCT ADC THERAPEUTICS SA
SVV SAVERS VALUE VILLAGE INC
GUTS FRACTYL HEALTH INC
LRCX LAM RESEARCH CORPORATION
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Upgrading Consumer Discretionary (XLY) to Overweight A weak 20-year note auction last Wednesday sparked the first semi-meaningful pullback since this lockout rally began on April 22nd, which is when we turned short-term bullish (4/22/25 Compass) as the SPX was testing 5100-5120 support. We will be watching the 10- and 30-year Treasury yields closely, as both are approaching important resistance levels (more on that below). Unsurprisingly, SPX only tested short-term gap support on the pullback a...
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare...
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present during the 2025 Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 2:35 p.m. ET in New York. A live webcast of the presentation will be available and in the investors section of the company’s website at . The webcast will be archived for at least 30 ...
- Jonathan Moreland
GPMT GRANITE POINT MORTGAGE TRUST INC.
BCBP BCB BANCORP INC.
PMTS CPI CARD GROUP
MPB MID PENN BANCORP INC.
KKR KKR & CO. INC.
FGBI FIRST GUARANTY BANCSHARES
REZI RESIDEO TECHNOLOGIES
LBSRD INC.
XRX LIBERTY STAR URANIUM & METALS
AVTR XEROX HOLDINGS CORPORATION
VLA AVANTOR
BHRB INC.
OPAL ARBOR METALS
VFC BURKE & HERBERT BANK & TR/VA
UHG OPAL FUELS INC
STRW VF CORPORATION
HYLN UNITED HOMES GROUP INC
NCDL STRAWBERRY FIELDS REIT INC.
PROP HYLIION HOLDINGS CORP.
EVM NUVEEN CHURCHILL DIRECT LENDING CORP
PRAIRIE OPERATING CO.
EATON VANCE INSD CALIF MUN BD FD
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.